Control of resection margins after neoadjuvant systemic therapy in breast-conserving surgery in breast cancer patients
Authors:
- Petr V. KrivorotkoPKPetr V. Krivorotko
- Yana I. BondarchukYBYana I. Bondarchuk
- Roman V. DonskihRDRoman V. Donskih
- Elena K. ZhiltsovaEZElena K. Zhiltsova
- Nikolay S. AmirovNANikolay S. Amirov
- Sergey S. BagnenkoSBSergey S. Bagnenko
- Antonina V. ChernayaACAntonina V. Chernaya
- Roman S. PesotskiyRPRoman S. Pesotskiy
- Alexander S. EmelyanovAEAlexander S. Emelyanov
- Viktoria V. MortadaVMViktoria V. Mortada
- Tengiz T. TabaguaTTTengiz T. Tabagua
- Larisa P. GigolaevaLGLarisa P. Gigolaeva
Open Access
- 5 May 2023
- journal article
- research article
- Published by ECO-Vector LLC in HERALD of North-Western State Medical University named after I.I. Mechnikov
- Vol. 15 (1) , 87-95
Abstract
BACKGROUND: Surgical treatment of breast cancer plays a major role in the combined and complex treatment of patients. The purity of the examined edges of the resected breast tissue is the main indicator of the reliability of the breast-conserving surgery and one of the main factors in the development of local recurrence. Neoadjuvant (preoperative) systemic therapy allows evaluating the effectiveness of therapy in vivo and reducing the size of the initial formation, both in locally advanced and resectable forms of breast cancer. The main advantage of this treatment is the ability for surgeons to perform breast-conserving surgery to improve patients quality of life and aesthetic outcomes without compromising disease-free and overall survival. AIM: To study the clinical and pathological characteristics and analyze of the breast-conserving surgery in patients with breast cancer after neoadjuvant chemotherapy. MATERIALS AND METHODS: 156 performed breast-conserving surgery after neoadjuvant chemotherapy were analyzed. Breast-conserving resection implied radical removal of the residual tumor node within healthy breast tissues with the achievement of negative resection margins. If pathologists detected stained invasive cells/cancer in situ in a formalin-fixed preparation, a second surgical intervention was performed. RESULTS: Of the 156 studied anatomical preparations after breast-conserving surgery, a positive margin was found in 4 (2.56%) cases. In 4 patients, positive margin was represented by ductal carcinoma in situ. According to the results of trephine biopsy, no intraductal component was found before neoadjuvant chemotherapy. The greatest length of the ductal carcinoma in situ section is 2.2 mm. In 3 cases, the distance to the stained resection margin of the micropreparation was 1 mm. As a result of repeated pathomorphological examination of pre-cut margins after surgical intervention, cancer in situ was not found. CONCLUSIONS: The ongoing neoadjuvant systemic therapy for breast cancer with a partial or complete response of the tumor increases the percentage of breast-conserving surgery performed in patients who initially belong to the group of radical mastectomy, but who want to save breast tissue.Keywords
This publication has 14 references indexed in Scilit:
- Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomesBreast Cancer Research and Treatment, 2017
- Neoadjuvant chemotherapy in breast-conserving surgery – Consequences on margin status and excision volumesEuropean Journal of Surgical Oncology, 2016
- Intraoperative Ultrasound-Guided Lumpectomy Versus Mammographic Wire Localization for Breast Cancer Patients After Neoadjuvant TreatmentAnnals of Surgical Oncology, 2015
- The role of radioactive iodine-125 seed localization in breast-conserving therapy following neoadjuvant chemotherapyAnnals of Oncology, 2012
- Network Meta-analysis of Margin Threshold for Women With Ductal Carcinoma In SituJNCI: Journal of the National Cancer Institute, 2012
- Impact of Preoperative Versus Postoperative Chemotherapy on the Extent and Number of Surgical Procedures in Patients Treated in Randomized Clinical Trials for Breast CancerAnnals of Surgery, 2006
- Intra-operative specimen analysis using faxitron microradiography for excision of mammographically suspicious, non-palpable breast lesionsThe Breast, 2004
- Breast Conservation After Neoadjuvant Chemotherapy: The M.D. Anderson Cancer Center ExperienceJournal of Clinical Oncology, 2004
- Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast CancerNew England Journal of Medicine, 2002
- Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast CancerNew England Journal of Medicine, 2002